Ratge D, Bauersfeld W, Wisser H
J Neural Transm. 1985;62(3-4):267-84. doi: 10.1007/BF01252241.
The concentration of free and conjugated norepinephrine (NE), epinephrine (E) and dopamine (DA) were measured by a modified radio-enzymatic assay in the plasma and in the cerebrospinal fluid (CSF) of 45 patients with normal and in 21 patients with disturbed blood-CSF barriers. In patients with an undisturbed blood-CSF barrier the free NE and E in CSF were 128 +/- 45 ng/l and 27 +/- 20 ng/l (mean values +/- S.E.), respectively, and represented about 50% of the average plasma values. Mean DA was not different in plasma (47 +/- 22 ng/l) and in CSF (41 +/- 19 ng/l). Both in plasma and in CSF, considerable higher free catecholamine (CA) levels were measured in patients with dysfunction of the blood-CSF barrier. In one patient with bacterial meningitis twofold higher concentrations of free NE and DA in CSF as compared with plasma were detectable. Sulfate conjugates of catecholamines are predominant in plasma and CSF. The contribution of conjugated CA to total CA in plasma from patients with normal blood-CSF barrier averaged 69.7%, 63.1% and 98.1% for NE, E and DA, respectively and was significantly lower in the CSF (p less than 0.001). In patients with disturbed blood-CSF barrier, the increases of conjugated CA were more pronounced in CSF than in plasma. Further, the contribution of conjugated NE and E to total NE and E in CSF was not only increased in patients with bacterial meningitis, but also in patients with renal insufficiency compared to the "control" patients (p less than 0.02 and p less than 0.001 resp.). Free and conjugated NE, E and DA in the plasma and CSF were related significantly (p less than 0.01 resp.) with stronger correlation for conjugated CA (p less than 0.001 resp.). These results together with findings in the literature, suggest that there is little or no rostral-caudal gradient in CSF CA conjugate concentrations and that even in patients with intact blood-CSF barrier plasma conjugated CA concentrations influence those in CSF. Thus only free CA levels in CSF may reflect the central adrenergic activity.
采用改良的放射酶法测定了45例血脑屏障正常患者及21例血脑屏障受损患者血浆和脑脊液(CSF)中游离和结合的去甲肾上腺素(NE)、肾上腺素(E)及多巴胺(DA)的浓度。血脑屏障未受损患者脑脊液中游离NE和E分别为128±45 ng/L和27±20 ng/L(均值±标准误),约占血浆平均水平的50%。血浆和脑脊液中DA的均值无差异(分别为47±22 ng/L和41±19 ng/L)。血脑屏障功能障碍患者血浆和脑脊液中游离儿茶酚胺(CA)水平均显著升高。1例细菌性脑膜炎患者脑脊液中游离NE和DA浓度比血浆中高出两倍。儿茶酚胺的硫酸盐结合物在血浆和脑脊液中占主导地位。血脑屏障正常患者血浆中结合CA占总CA的比例,NE、E和DA分别平均为69.7%、63.1%和98.1%,在脑脊液中则显著降低(p<0.001)。血脑屏障受损患者脑脊液中结合CA的增加比血浆中更明显。此外,与“对照”患者相比,细菌性脑膜炎患者及肾功能不全患者脑脊液中结合NE和E占总NE和E的比例不仅增加(分别为p<0.02和p<0.001)。血浆和脑脊液中游离及结合的NE、E和DA显著相关(分别为p<0.01),结合CA的相关性更强(分别为p<0.001)。这些结果以及文献中的发现表明,脑脊液中CA结合物浓度几乎没有或不存在头-尾梯度,即使血脑屏障完整的患者,血浆结合CA浓度也会影响脑脊液中的浓度。因此,只有脑脊液中游离CA水平可能反映中枢肾上腺素能活性。